Global Helicobacter Pylori Diagnostics Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Type;

Instruments, Reagents, and Services

By Test Type;

Non-Invasive Test, and Invasive Test

By Method;

Laboratory Based Test, and Point of Care Test

By Technology;

Immunoassays, POC, and Molecular Diagnostics

By End Users;

Hospitals, Diagnostic Centers, Clinics, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn782111977 Published Date: May, 2025 Updated Date: June, 2025

Introduction

Global Helicobacter Pylori Diagnostics Market (USD Million), 2021 - 2031

Helicobacter Pylori Diagnostics Market was valued at USD 6,895.79 million in the year 2024. The size of this market is expected to increase to USD 10,921.90 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.8%.


Global Helicobacter Pylori Diagnostics Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 6.8 %


Study Period2025 - 2031
Base Year2024
CAGR (%)6.8 %
Market Size (2024)USD 6,895.79 Million
Market Size (2031)USD 10,921.90 Million
Market ConcentrationMedium
Report Pages331
6,895.79
2024
10,921.90
2031

Major Players

  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories Inc.
  • Diasorin S.P.A.
  • Quidel Corporation
  • F. Hoffmann-La Roche Ltd. (Ventana Medical Systems, Inc.)
  • Meridian Bioscience, Inc.
  • Exalenz Bioscience Ltd.
  • Abbott Laboratories
  • Cardinal Health, Inc.
  • Halyard Health, Inc.

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Helicobacter Pylori Diagnostics Market

Fragmented - Highly competitive market without dominant players


The Helicobacter Pylori Diagnostics Market is experiencing steady growth, driven by the rising prevalence of Helicobacter pylori infections, which impact nearly 50% of the population. This bacterium is a primary cause of gastritis, peptic ulcers, and stomach cancer, fueling demand for accurate diagnostic solutions. With a focus on early detection and effective treatment, healthcare systems are increasingly adopting advanced diagnostics to reduce the long-term health risks associated with this infection.

Technological Innovations Driving Market Growth
Technological advancements are transforming the landscape of Helicobacter pylori diagnostics. The integration of real-time PCR and enzyme immunoassays (EIA), which together make up nearly 40% of diagnostic solutions, has significantly improved test sensitivity and specificity. These innovations are helping to reduce false positives and provide precise, reliable results, thereby boosting overall market growth.

Emphasis on Early Detection and Disease Management
Early detection of H. pylori infections is crucial for effective treatment and prevention of severe complications. With nearly 35% of diagnostic efforts now focused on early detection, healthcare providers are prioritizing preventive care to reduce morbidity and treatment costs. This proactive approach reflects a broader shift towards preventive healthcare, aimed at reducing the long-term burden of gastric disorders.

Rising Healthcare Awareness Supporting Market Expansion
The market is also benefiting from increased healthcare awareness and widespread screening programs, particularly in regions with a high prevalence of H. pylori infections. Currently, over 55% of healthcare providers emphasize early diagnosis in their patient care strategies, highlighting the growing importance of timely and accurate diagnostics in improving patient outcomes and overall healthcare quality.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Test Type
    3. Market Snapshot, By Method
    4. Market Snapshot, By Technology
    5. Market Snapshot, By End Users
    6. Market Snapshot, By Region
  4. Global Helicobacter Pylori Diagnostics Market, Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising prevalence of Helicobacter pylori infections
        2. Rising Awareness of H. pylori-related Diseases
        3. Growing Healthcare Expenditure
      2. Restraints
        1. High Cost of Advanced Diagnostic Tools
        2. Limited Access to Healthcare in Developing Regions
        3. Lack of Skilled Healthcare Professionals
      3. Opportunities
        1. Development of Point-of-Care Testing
        2. Adoption of Non-Invasive Diagnostic Methods
        3. Expansion of Healthcare Infrastructure
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Helicobacter Pylori Diagnostics Market, By Type, 2021 - 2031 (USD Million)
      1. Instruments
      2. Reagents
      3. Services
    2. Global Helicobacter Pylori Diagnostics Market, By Test Type, 2021 - 2031 (USD Million)
      1. Non-Invasive Test
      2. Invasive Test
    3. Global Helicobacter Pylori Diagnostics Market, By Method, 2021 - 2031 (USD Million)
      1. Laboratory Based Test
      2. Point of Care Test
    4. Global Helicobacter Pylori Diagnostics Market, By Technology, 2021 - 2031 (USD Million)
      1. Immunoassays
      2. POC
      3. Molecular Diagnostics
    5. Global Helicobacter Pylori Diagnostics Market, By End Users, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Diagnostic Centers
      3. Clinics
      4. Others
    6. Global Helicobacter Pylori Diagnostics Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Thermo Fisher Scientific, Inc.
      2. Bio-Rad Laboratories Inc.
      3. Diasorin S.P.A.
      4. Quidel Corporation
      5. F. Hoffmann-La Roche Ltd. (Ventana Medical Systems, Inc.)
      6. Meridian Bioscience, Inc.
      7. Exalenz Bioscience Ltd.
      8. Abbott Laboratories
      9. Cardinal Health, Inc.
      10. Halyard Health, Inc.
  7. Analyst Views
  8. Future Outlook of the Market